Dose Response of MARV/Angola Infection in Cynomolgus Macaques following IM or Aerosol Exposure.

Sara C Johnston, Kenny L Lin, Nancy A Twenhafel, Jo Lynne W Raymond, Joshua D Shamblin, Suzanne E Wollen, Carly B Wlazlowski, Eric R Wilkinson, Miriam A Botto, Arthur J Goff
Author Information
  1. Sara C Johnston: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  2. Kenny L Lin: Nonclinical Development Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  3. Nancy A Twenhafel: Pathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  4. Jo Lynne W Raymond: Pathology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  5. Joshua D Shamblin: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  6. Suzanne E Wollen: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  7. Carly B Wlazlowski: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  8. Eric R Wilkinson: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  9. Miriam A Botto: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.
  10. Arthur J Goff: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, 21702, United States of America.

Abstract

Marburg virus infection in humans causes a hemorrhagic disease with a high case fatality rate. Countermeasure development requires the use of well-characterized animal models that mimic human disease. To further characterize the cynomolgus macaque model of MARV/Angola, two independent dose response studies were performed using the intramuscular or aerosol routes of exposure. All animals succumbed at the lowest target dose; therefore, a dose effect could not be determined. For intramuscular-exposed animals, 100 PFU was the first target dose that was not significantly different than higher target doses in terms of time to disposition, clinical pathology, and histopathology. Although a significant difference was not observed between aerosol-exposed animals in the 10 PFU and 100 PFU target dose groups, 100 PFU was determined to be the lowest target dose that could be consistently obtained and accurately titrated in aerosol studies.

References

  1. J Infect Dis. 2007 Nov 15;196 Suppl 2:S372-81 [PMID: 17940973]
  2. Br Med J. 1975 Nov 29;4(5995):489-93 [PMID: 811315]
  3. Lancet. 2011 Mar 5;377(9768):849-62 [PMID: 21084112]
  4. J Virol. 2015 Oct;89(19):9875-85 [PMID: 26202230]
  5. Curr Top Microbiol Immunol. 1999;235:49-75 [PMID: 9893378]
  6. Naturwissenschaften. 1999 Jan;86(1):8-17 [PMID: 10024977]
  7. Semin Pediatr Infect Dis. 2005 Jul;16(3):219-24 [PMID: 16044395]
  8. Acad Med. 2005 Dec;80(12):1079-85 [PMID: 16306276]
  9. J Infect Dis. 2007 Nov 15;196 Suppl 2:S148-53 [PMID: 17940943]
  10. Antiviral Res. 2002 Apr;54(1):1-17 [PMID: 11888653]
  11. Trop Med Int Health. 2002 Oct;7(10):902-6 [PMID: 12358627]
  12. Lancet. 1982 Apr 10;1(8276):816-20 [PMID: 6122054]
  13. Vet Pathol. 2010 Sep;47(5):831-51 [PMID: 20807825]
  14. Emerg Infect Dis. 2003 Dec;9(12):1531-7 [PMID: 14720391]
  15. Lancet Infect Dis. 2004 Aug;4(8):487-98 [PMID: 15288821]
  16. Ger Med Mon. 1968 Oct;13(10):457-70 [PMID: 4974179]
  17. J Gen Virol. 1988 Aug;69 ( Pt 8):1957-67 [PMID: 3404120]

MeSH Term

Aerosols
Animals
Injections, Intramuscular
Kaplan-Meier Estimate
Macaca fascicularis
Marburg Virus Disease
Marburgvirus
RNA, Viral
Temperature

Chemicals

Aerosols
RNA, Viral

Word Cloud

Created with Highcharts 10.0.0dosetargetPFUanimals100diseaseMARV/AngolastudiesaerosollowestdeterminedMarburgvirusinfectionhumanscauseshemorrhagichighcasefatalityrateCountermeasuredevelopmentrequiresusewell-characterizedanimalmodelsmimichumancharacterizecynomolgusmacaquemodeltwoindependentresponseperformedusingintramuscularroutesexposuresuccumbedthereforeeffectintramuscular-exposedfirstsignificantlydifferenthigherdosestermstimedispositionclinicalpathologyhistopathologyAlthoughsignificantdifferenceobservedaerosol-exposed10groupsconsistentlyobtainedaccuratelytitratedDoseResponseInfectionCynomolgusMacaquesfollowingIMAerosolExposure

Similar Articles

Cited By